Professor Chris Mason (UCL Biochemical Engineering) says that
if confirmed in a clinical trial, using a one-off transplant of
laboratory-grown pancreatic cells to treat diabetes, would be "a medical
game-changer on a par with antibiotics and bacterial infections".
Read:
Telegraph,
More: Independent,
BBC News,
Times (£),
Daily Mail
Close
